IMMUNOHISTOLOGIC STUDIES OF TYPE-IV COLLAGEN IN ANTERIOR LENS CAPSULES OF PATIENTS WITH ALPORT SYNDROME

被引:2
|
作者
CHEONG, HI [1 ]
KASHTAN, CE [1 ]
KIM, Y [1 ]
KLEPPEL, MM [1 ]
MICHAEL, AF [1 ]
机构
[1] UNIV MINNESOTA,SCH MED,DEPT PEDIAT,DIV PEDIAT NEPHROL,MINNEAPOLIS,MN 55455
关键词
ANTERIOR LENTICONUS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND: Alport syndrome is an inherited disorder affecting the kidney, eye and ear arising from mutations in the gene COL4A5, which encodes the alpha 5 chain of type IV collagen. Structural defects of glomerular basement membranes in Alport syndrome are associated in most instances with failure to detect the alpha 3, alpha 4, and alpha 5 chains of type IV collagen as well as the Alport antigen that is identified in normal tissues by a genetically discriminating alloantibody and monoclonal antibody. Anterior lenticonus is an ocular abnormality pathognomonic of Alport syndrome that is associated with marked thinning of the anterior lens capsule (ALC). The reactivity of Alport ALC with type IV collagen antibodies has not previously been reported. EXPERIMENTAL DESIGN: ALCs were obtained at the time of cataract extraction from two unrelated males with Alport syndrome and anterior lenticonus, and stained with antibodies against the alpha 1, alpha 2, alpha 3 and alpha 4 chains of type IV collagen, as well as an antibody against the alpha 5(IV) chain. Controls consisted of ALCs from a normal individual and from a patient with diabetes mellitus. RESULTS: Normal and diabetic ALCs reacted with antibodies against the alpha 1, alpha 2, alpha 3, and alpha 4 chains of type IV collagen and the alpha 5(IV) chain. In one of the Alport patients, ALC showed no reactivity with antibodies against the alpha 5(IV) chain and the alpha 3 and alpha 4 chains of type IV collagen. In the second patient, ALC reactivity with these antibodies was preserved. Epidermal basement membranes from this second patient also showed reactivity with antibody against the alpha 5(IV) chain, unlike most males with Alport syndrome. In both Alport patients, ALCs reacted with antibodies against the alpha 1(IV) and alpha 2(IV) chains. CONCLUSIONS: These findings suggest that anterior lenticonus in patients with Alport syndrome may be associated with absence of the alpha 3 and alpha 4 chains of type IV collagen, as well as the alpha 5(IV) chain, from anterior lens capsule. On the other hand, these chains may be present in Alport patients with anterior lenticonus. The precise structural basis for mechanical weakness of the anterior lens capsule in patients with Alport syndrome remains to be determined.
引用
收藏
页码:553 / 557
页数:5
相关论文
共 50 条
  • [1] Ultrastructural fragility and type IV collagen abnormality of the anterior lens capsules in a patient with Alport syndrome
    Takei, K
    Furuya, A
    Hommura, S
    Yamaguchi, N
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2001, 45 (01) : 103 - 104
  • [2] TYPE-IV COLLAGEN AND ALPORT SYNDROME
    KNEBELMANN, B
    M S-MEDECINE SCIENCES, 1991, 7 (05): : 510 - 511
  • [3] Alport syndrome: Clinical and genetic correlation in a type-IV collagen disease
    Netzer, KO
    Gross, O
    Jung, C
    Kirsten, R
    Seibold, S
    Leinonen, A
    Weber, M
    HEREDITARY KIDNEY DISEASES, 1997, 122 : 116 - 123
  • [4] AUTOSOMAL RECESSIVE ALPORT SYNDROME - IMMUNOHISTOCHEMICAL STUDY OF TYPE-IV COLLAGEN CHAIN DISTRIBUTION
    GUBLER, MC
    KNEBELMANN, B
    BEZIAU, A
    BROYER, M
    PIRSON, Y
    HADDOUM, F
    KLEPPEL, MM
    ANTIGNAC, C
    KIDNEY INTERNATIONAL, 1995, 47 (04) : 1142 - 1147
  • [5] ALLELISM OF ALPORT SYNDROME (AS) TYPE-III AND TYPE-IV
    GREGORY, M
    ATKIN, C
    GOLDGAR, D
    BARKER, D
    SKOLNICK, M
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 248 - 248
  • [6] A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients
    Chen, N
    Pan, XX
    Ren, H
    Dong, DC
    CHINESE MEDICAL JOURNAL, 1998, 111 (09) : 797 - 802
  • [7] Clinicopathological study of Children Alport syndrome and distribution features of type IV collagen in Alport patients
    Qiu, Guixia
    Wang, Mo
    Li, Qiu
    Tang, Xuemei
    Shi, Jisheng
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1546 - 1546
  • [8] A MONOCLONAL-ANTIBODY MARKER FOR ALPORT SYNDROME IDENTIFIES THE ALPORT ANTIGEN AS THE ALPHA-5 CHAIN OF TYPE-IV COLLAGEN
    DING, J
    KASHTAN, CE
    FAN, WW
    KLEPPEL, MM
    SUN, MJ
    KALLURI, R
    NEILSON, EG
    MICHAEL, AF
    KIDNEY INTERNATIONAL, 1994, 45 (05) : 1504 - 1506
  • [9] A FRAMESHIFT MUTATION IN THE TYPE-IV COLLAGEN ALPHA-3 GENE IN AUTOSOMAL RECESSIVE ALPORT SYNDROME
    LEMMINK, H
    VANDENHEUVEL, L
    KLUIJTMANS, L
    MOCHIZUKI, T
    REEDERS, S
    MONNENS, L
    SCHRODER, C
    BRUNNER, H
    SMEETS, H
    KIDNEY INTERNATIONAL, 1994, 46 (05) : 1461 - 1461
  • [10] COCHLEAR BASEMENT-MEMBRANE - IDENTIFICATION AND LOCALIZATION OF TYPE-IV COLLAGEN CHAINS AND IMPLICATIONS FOR ALPORT SYNDROME
    KALLURI, R
    GATTONE, VH
    HUDSON, BG
    FASEB JOURNAL, 1994, 8 (07): : A1452 - A1452